 comparison MU interferon placebo patient chronic non-a non-b hepat nineti patient chronic non-a non-b hepat SC inject placebo MU recombin interferon time week complet normal alanin aminotransferas level posttreat patient MU MU untreat patient MU alanin aminotransferas normal month therapi patient MU MU placebo declin alanin aminotransferas level interferon therapi independ posit correl femal sex age knodel fibrosi score age MU interferon effect dose MU diseas activ non-a non-b chronic hepat patient women noncirrhot patient like